Precure Targeted Accrual and Rapid Growth in Enrollment Trial (TARGET) Study
试验速览
- 阶段
- 不适用
- 状态
- Enrolling By Invitation
- 发起方
- Mayo Clinic
- 入组人数
- 100,000
- 试验地点
- 1
- 主要终点
- Number of participants (up to 100,000) who provide biospecimens and have associated environmental exposure and phenotypic data successfully linked and stored within the biorepository and research database for future research.
研究概览
简要总结
The goal of this observational study is to 1) better understand and predict biological processes before disease begins or is identified, 2) study genomic and environmental contributors to disease, 3) identify ways to stop disease advancement before it becomes serious or complex, and 4) identify potential targets for disease therapy.
Participants will be asked to:
- collect biological samples
研究设计
- 研究类型
- Observational
- 观察模型
- Ecologic Or Community
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Age ≥ 18 years
- •Registered Mayo Clinic patient
- •Able to provide informed consent
排除标准
- •Other co-morbidity that, in physician's opinion, would interfere with patient's ability to participate in the study
结局指标
主要结局
Number of participants (up to 100,000) who provide biospecimens and have associated environmental exposure and phenotypic data successfully linked and stored within the biorepository and research database for future research.
时间窗: Up to 5 years
次要结局
未报告次要终点
研究者
Konstantinos N. Lazaridis, M.D.
Executive Director, Center for Individualized Medicine
Mayo Clinic
